Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2005
Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinomaJens Teichert, Reinhard Sohr, Frank Baumann, et al.
Gut|August 12, 2017
Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indicationsArthur Schmidt, Torsten Beyna, Brigitte Schumacher, et al.
European Neurology|August 21, 2002
Genotype correlation with fine motor symptoms in patients with Wilson's diseaseWieland Hermann, Karel Caca, Birk Eggers, et al.
Gastrointestinal Endoscopy|July 2, 2004
Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II studyMarcus Wiedmann, Frieder Berr, Ingolf Schiefke, et al.
Zeitschrift Fur Gastroenterologie|September 18, 2018
Doppler ultrasound surveillance of TIPS-patency in the era of covered stents - retrospective analysis of a large single-center cohortChristoph Klinger, Bettina Riecken, Johannes Müller, et al.
Surgery|November 18, 2005
Caroli's disease: liver resection and liver transplantation. Experience in 33 patientsWoubet Tefera Kassahun, Thomas Kahn, Christian Wittekind, et al.
Anti-Cancer Drugs|August 24, 2006
Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinibMarcus Wiedmann, Jürgen Feisthammel, Thilo Blüthner, et al.
Gastroenterology|January 31, 2003
Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell linesDominik Huster, Michael Hoppert, Svetlana Lutsenko, et al.
International Journal of Cancer|January 22, 2002
Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell linesKarel Caca, Jürgen Feisthammel, Karen Klee, et al.
World Journal of Gastroenterology|July 3, 2008
Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitorsMartin Haefner, Thilo Bluethner, Manuel Niederhagen, et al.
Pageof 17